Sample Finished Products Testing Sample Clauses
Sample Finished Products Testing. During the Term, Defiante shall supply, at no charge, to RegeneRx, within seven (7) days of RegeneRx's request, a small representative sample quantity of units of Finished Products for the purposes of internal use and evaluation by RegeneRx. CERTAIN PORTIONS OF THIS DOCUMENT INDICATED BY *** HAVE BEEN REDACTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT Upon Defiante's request, RegeneRx shall inform Defiante of its use and evaluation findings. Such findings shall be considered Information to RegeneRx. The foregoing shall be applicable to Sub-Licensees.
Sample Finished Products Testing. During the Term, Defiante shall supply, at no charge, to RegeneRx, within seven (7) days of RegeneRx's request, a small representative sample quantity of units of Finished Products for the purposes of internal use and evaluation by RegeneRx. Upon Defiante's request, RegeneRx shall inform Defiante of its use and evaluation findings. Such findings shall be considered Information to RegeneRx. The foregoing shall be applicable to Sub-Licensees. CERTAIN PORTIONS OF THIS DOCUMENT INDICATED BY *** HAVE BEEN REDACTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT 6.8 RegeneRx Improvements/Defiante Improvements/Joint Improvements Incorporation Authorizations.
(a) In the event that Defiante desires to use or incorporate Joint Improvements, RegeneRx Improvements or Defiante Improvements in the Bulk Active Material and/or Finished Products, Defiante is free to do so except in the case where such Joint Improvements, RegeneRx Improvements or Defiante Improvements constitute substantive changes to the Bulk Active Material and/or Finished Products. Substantive changes shall be interpreted to include any and all changes that cause non-compliance with the Specifications, or cause non-compliance with the Commercial Marketing Approvals required for the Finished Products. In the case of substantive changes, both parties must review and mutually approve all such changes prior to such changes being incorporated into the Finished Products. In the event no mutual agreement is reached, the provisions of Section 6.8(c) shall govern. Defiante shall be considered in breach of this Agreement if Defiante incorporates into the Bulk Active Material and/or Finished Products any substantive changes relative to Joint Improvements, RegeneRx Improvements or Defiante Improvements without the mutual agreement of the parties hereto. If both parties mutually agree that such Bulk Active Material and/or Finished Products, incorporating Joint Improvements, RegeneRx Improvements or Defiante Improvements, comply with the Specifications and Commercial Marketing Approval, as the case may be, Defiante may begin production manufacturing of such Finished Products for Sales to Customers.
(b) Prior to engaging in Sales of Finished Products incorporating Joint Improvements, RegeneRx Improvements or Defiante Improvements, Defiante shall supply to RegeneRx, at no charge, at least a representative number of sample quantities of units of Finished Products using or incorporating such Joint Improvements, RegeneRx ...
